Vietnamese Journal of Neurology

Article detail

Article detail description

Home
Tổng quan Issue: Số 33 - 2022 Thần kinh nhiễm trùng

Neurological Complications of COVID-19

Published: June 15, 2022
Lượt đọc: 0

Abstract

Progressive supranuclear palsy (PSP) is the most common neurodegenerative disorder among atypical parkinsonian syndromes. It is clinically characterized by vertical supranuclear gaze palsy, postural instability with recurrent unexplained falls, bradykinesia, and cognitive impairment. Neuropathologically, PSP is defined by the abnormal accumulation of tau protein and is classified as a primary tauopathy. Early recognition of its clinical features and underlying pathology is essential for accurate diagnosis, differential diagnosis, and patient management.

Keywords
Progressive supranuclear palsy Atypical parkinsonism Tau protein Movement disorders

References

1.
Lechien JR et al. 2020. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol.
2.
Muhammad Umer Ahmed et al. 2020. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review, Front. Neurol.
3.
Ghaydaa A. Shehata et al. 2021. Neurological Complications of COVID-19: Underlying Mechanisms and Management, Int J Mol Sci. 
4.
Neo Poyiadji et al. 2020. COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features, Radiology.
5.
Shashank Agarwal, Rajan Jain et al 2020 Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19, Stroke, Vol 51, No 9.
6.
Sedat G. Kandemirli et al. 2020 Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection, RadiologyVol. 297, No. 1
7.
Moriguchi T, Harii N, Goto J, Haradaa D, Sugawaraa H, Takamino J, et al. 2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis.
8.
Carfì A, Bernabei R, Landi F, et al. 2020 Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324:603.
9.
Xiong Q, Xu M, Li J, et al.2020 Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2020.
10.
Hopkins C, Surda P, Whitehead E, Kumar BN. Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J Otolaryngol Head Neck Surg 2020; 49:26.
11.
Cho RHW, To ZWH, Yeung ZWC, et al. COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction. Laryngoscope 2020; 130:2680.
12.
Meini S, Suardi LR, Busoni M, et al. Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Otorhinolaryngol 2020; 277:3519.
13.
Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2020.
14.
Bowles KH, McDonald M, Barrón Y, et al. Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients. Ann Intern Med 2020.
15.
Wong AW, Shah AS, Johnston JC, et al. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J 2020; 56.
16.
Nehme M, Braillard O, Alcoba G, et al. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med 2020.
17.
Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2020.
18.
Logue J K; Franko N M; McCulloch D J; et al. Sequelae in Adults at 6 Months After COVID-19 Infection JAMA Network Open. 2021;4(2):e210830.
19.
Mandal S, Barnett J, Brill S, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2020; PMID 33172844.
20.
Bellan M, Soddu D, Balbo PE, et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021;4(1):e2036142.
21.
Writing Committee for the COMEBAC Study Group, Morin L, Savale L, Pham T, et al. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021; PMID 33729425.
22.
Del Brutto OH, Wu S, Mera A, Recalde et al. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort. Eur J Neurol 2021; PMID 33576150.
23.
Heesakkers H, van der Hoeven JG, Corsten S, et al. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA 2022; PMID 35072716.

Authors

Võ Hồng Khôi Bệnh viện Bạch Mai, Đại học Y Hà Nội, Đại học Y Dược Đại học Quốc gia Hà Nội

Trung tâm Thần kinh Bệnh viện Bạch Mai
Bộ môn Thần kinh, Đại học Y Hà Nội
Bộ môn Thần kinh, Đại học Y Dược Đại học Quốc gia Hà Nội

 Nguyễn Hải Anh Bệnh viện Bạch Mai, Đại học Y Dược Đại học Quốc gia Hà Nội

Trung tâm Thần kinh Bệnh viện Bạch Mai
Bộ môn Thần kinh, Đại học Y Dược Đại học Quốc gia Hà Nội
Neurological Complications of COVID-19

Files

PDF

Trích dẫn

APA

Định dạng

Tải trích dẫn

Article Views0
Document Views0
Downloads0
Section Tổng quan
Issue Số 33 - 2022
Category Thần kinh nhiễm trùng
Pages 22-30
Copyright Holder 2022 Vietnamese Journal of Neurology